SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer’s Disease
Titel:
SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer’s Disease
Auteur:
Trujillo-Estrada, Laura Vanderklish, Peter W. Nguyen, Marie Minh Thu Kuang, Run Rong Nguyen, Caroline Huynh, Eric da Cunha, Celia Javonillo, Dominic Ibarra Forner, Stefania Martini, Alessandra C. Sarraf, Stella T. Simmon, Vincent F. Baglietto-Vargas, David LaFerla, Frank M.